Pages that link to "Q35794127"
Jump to navigation
Jump to search
The following pages link to A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding (Q35794127):
Displaying 9 items.
- HIV entry inhibitors: mechanisms of action and resistance pathways (Q28296162) (← links)
- N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion (Q33208281) (← links)
- Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor (Q33223969) (← links)
- Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41 (Q34483474) (← links)
- Highly potent chimeric inhibitors targeting two steps of HIV cell entry (Q35150195) (← links)
- Blocking HIV-1 entry by a gp120 surface binding inhibitor (Q36806392) (← links)
- Inhibition of HIV‐1 Entry: Multiple Keys to Close the Door (Q37789226) (← links)
- Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120. (Q39283283) (← links)
- Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitors (Q42140292) (← links)